We found that 179 (20.7%) of the patients who did not achieve pCR had a DCIS component in the pre-NAC specimen: 101 luminal (21.2%), 24 TNBC (11%) and 54 HER2-positive BCs (31.6%). Here, ERBB2 is linked to ductal breast carcinoma in situ.